Literature DB >> 35351360

BRCA1/BARD1 is a nucleosome reader and writer.

Samuel R Witus1, Weixing Zhao2, Peter S Brzovic1, Rachel E Klevit3.   

Abstract

Mutations in BRCA1 and BARD1 predispose carriers to breast and ovarian cancers. The BRCA1 and BARD1 proteins form a heterodimeric complex (BRCA1/BARD1) that regulates many biological processes, including transcription and DNA double-stranded break repair. These functions are mediated by the only known enzymatic activity of BRCA1/BARD1 in its capacity as an E3 ubiquitin ligase and its role as a central hub for many large protein complexes. But the mechanisms by which BRCA1/BARD1 interfaces with chromatin, where it exerts its major functions, have remained unknown. Here, we review recent advancements in structural and cellular biology that have provided critical insights into how BRCA1/BARD1 serves as both a nucleosome reader and writer to facilitate transcriptional regulation and DNA repair by homologous recombination.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA damage repair; chromatin regulation; homologous recombination; transcriptional regulation; ubiquitin ligase

Mesh:

Substances:

Year:  2022        PMID: 35351360      PMCID: PMC9189015          DOI: 10.1016/j.tibs.2022.03.001

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   14.264


  82 in total

1.  The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.

Authors:  R Hashizume; M Fukuda; I Maeda; H Nishikawa; D Oyake; Y Yabuki; H Ogata; T Ohta
Journal:  J Biol Chem       Date:  2001-03-06       Impact factor: 5.157

Review 2.  The diversity of ubiquitin recognition: hot spots and varied specificity.

Authors:  Jason M Winget; Thibault Mayor
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

3.  Crystal structure of the BARD1 ankyrin repeat domain and its functional consequences.

Authors:  David Fox; Isolde Le Trong; Ponni Rajagopal; Peter S Brzovic; Ronald E Stenkamp; Rachel E Klevit
Journal:  J Biol Chem       Date:  2008-05-14       Impact factor: 5.157

4.  Structural insight into BRCA1-BARD1 complex recruitment to damaged chromatin.

Authors:  Linchang Dai; Yaxin Dai; Jinhua Han; Yan Huang; Longge Wang; Jun Huang; Zheng Zhou
Journal:  Mol Cell       Date:  2021-06-07       Impact factor: 17.970

5.  Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection.

Authors:  Ruth M Densham; Alexander J Garvin; Helen R Stone; Joanna Strachan; Robert A Baldock; Manuel Daza-Martin; Alice Fletcher; Sarah Blair-Reid; James Beesley; Balraj Johal; Laurence H Pearl; Robert Neely; Nicholas H Keep; Felicity Z Watts; Joanna R Morris
Journal:  Nat Struct Mol Biol       Date:  2016-05-30       Impact factor: 15.369

6.  BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.

Authors:  Mikaela D Stewart; Elena Zelin; Abhinav Dhall; Tom Walsh; Esha Upadhyay; Jacob E Corn; Champak Chatterjee; Mary-Claire King; Rachel E Klevit
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-24       Impact factor: 11.205

7.  Evidence for a transcriptional activation function of BRCA1 C-terminal region.

Authors:  A N Monteiro; A August; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

8.  The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression.

Authors:  Reena Shakya; Matthias Szabolcs; Ellen McCarthy; Elson Ospina; Katia Basso; Subhadra Nandula; Vundavalli Murty; Richard Baer; Thomas Ludwig
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

9.  BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.

Authors:  Rinske Drost; Peter Bouwman; Sven Rottenberg; Ute Boon; Eva Schut; Sjoerd Klarenbeek; Christiaan Klijn; Ingrid van der Heijden; Hanneke van der Gulden; Ellen Wientjens; Mark Pieterse; Aurelie Catteau; Pete Green; Ellen Solomon; Joanna R Morris; Jos Jonkers
Journal:  Cancer Cell       Date:  2011-12-13       Impact factor: 31.743

10.  Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.

Authors:  Nana Weber-Lassalle; Julika Borde; Konstantin Weber-Lassalle; Judit Horváth; Dieter Niederacher; Norbert Arnold; Silke Kaulfuß; Corinna Ernst; Victoria G Paul; Ellen Honisch; Kristina Klaschik; Alexander E Volk; Christian Kubisch; Steffen Rapp; Nadine Lichey; Janine Altmüller; Louisa Lepkes; Esther Pohl-Rescigno; Holger Thiele; Peter Nürnberg; Mirjam Larsen; Lisa Richters; Kerstin Rhiem; Barbara Wappenschmidt; Christoph Engel; Alfons Meindl; Rita K Schmutzler; Eric Hahnen; Jan Hauke
Journal:  Breast Cancer Res       Date:  2019-04-29       Impact factor: 6.466

View more
  1 in total

1.  Functional Restoration of BRCA1 Nonsense Mutations by Aminoglycoside-Induced Readthrough.

Authors:  Renata B V Abreu; Thiago T Gomes; Thales C Nepomuceno; Xueli Li; Mateus Fuchshuber-Moraes; Giuliana De Gregoriis; Guilherme Suarez-Kurtz; Alvaro N A Monteiro; Marcelo A Carvalho
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.